Skip to main content
. 2014 Jun 12;2014:746574. doi: 10.1155/2014/746574

Figure 5.

Figure 5

The amount of MRI signal enhancement in the abdominal aorta of atherosclerotic rabbits following treatment with α ν β 3-integrin targeted fumagillin nanoparticles correlates with the therapeutic effect measured 1 week later. This finding suggests that combined imaging and therapeutic nanoparticles can be used to predict the treatment effects at the time of treatment. Reprinted with permission from [35].